FI60869C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara cefalosporiner - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara cefalosporiner Download PDF

Info

Publication number
FI60869C
FI60869C FI772860A FI772860A FI60869C FI 60869 C FI60869 C FI 60869C FI 772860 A FI772860 A FI 772860A FI 772860 A FI772860 A FI 772860A FI 60869 C FI60869 C FI 60869C
Authority
FI
Finland
Prior art keywords
mmol
mixture
formula
pyridazine
compound
Prior art date
Application number
FI772860A
Other languages
English (en)
Finnish (fi)
Other versions
FI772860A (fi
FI60869B (fi
Inventor
Takayuki Naito
Jun Okumura
Hajime Kamachi
Seiji Iimura
Hideaki Hoshi
Masahisa Oka
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/784,885 external-priority patent/US4082912A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI772860A publication Critical patent/FI772860A/fi
Publication of FI60869B publication Critical patent/FI60869B/fi
Application granted granted Critical
Publication of FI60869C publication Critical patent/FI60869C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI772860A 1977-04-05 1977-09-28 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara cefalosporiner FI60869C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78488577 1977-04-05
US05/784,885 US4082912A (en) 1976-06-30 1977-04-05 Certain 7-acylamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylmethyl)-3-cephem-4-carboxylic acids their salts and easily hydrolyzed esters

Publications (3)

Publication Number Publication Date
FI772860A FI772860A (fi) 1978-10-06
FI60869B FI60869B (fi) 1981-12-31
FI60869C true FI60869C (fi) 1982-04-13

Family

ID=25133827

Family Applications (1)

Application Number Title Priority Date Filing Date
FI772860A FI60869C (fi) 1977-04-05 1977-09-28 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara cefalosporiner

Country Status (17)

Country Link
JP (1) JPS53124290A (el)
AU (1) AU517919B2 (el)
BE (1) BE859774A (el)
CA (1) CA1113455A (el)
CH (1) CH627184A5 (el)
DE (1) DE2807847A1 (el)
DK (1) DK145497C (el)
FI (1) FI60869C (el)
FR (1) FR2408614A1 (el)
GB (1) GB1572201A (el)
GR (1) GR73550B (el)
IE (1) IE45613B1 (el)
LU (1) LU78323A1 (el)
NL (1) NL7711644A (el)
SE (1) SE425491B (el)
YU (1) YU247977A (el)
ZA (1) ZA775781B (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
CN114940665B (zh) * 2022-06-10 2024-05-07 河南省科学院高新技术研究中心 一种用作杀菌剂的苯并异噻唑啉酮类化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946000A (en) * 1973-10-31 1976-03-23 Bristol-Myers Company 7-[α-(2-Aminomethyl-1-cyclohexenyl)-acetamido]-3-heterocyclic thiomethyl-3-cephem-4-carboxylic acids
US3907786A (en) * 1973-09-04 1975-09-23 Bristol Myers Co 7-{8 {60 -(2-aminomethyl-1,4-cyclohexadienyl)acetamido{9 -3-heterocyclic-thiomethyl-3-cephem-4-carboxylic acids and salts

Also Published As

Publication number Publication date
SE7710823L (sv) 1978-10-06
DK429577A (da) 1978-10-06
LU78323A1 (el) 1978-06-12
SE425491B (sv) 1982-10-04
FI772860A (fi) 1978-10-06
GR73550B (el) 1984-03-13
AU517919B2 (en) 1981-09-03
IE45613B1 (en) 1982-10-06
DK145497C (da) 1983-05-02
FR2408614A1 (fr) 1979-06-08
ZA775781B (en) 1978-08-30
BE859774A (fr) 1978-04-14
FI60869B (fi) 1981-12-31
YU247977A (en) 1982-10-31
JPS53124290A (en) 1978-10-30
IE45613L (en) 1978-10-05
CH627184A5 (en) 1981-12-31
NL7711644A (nl) 1978-10-09
DE2807847A1 (de) 1978-10-19
FR2408614B1 (el) 1980-12-05
GB1572201A (en) 1980-07-23
AU2932877A (en) 1979-04-12
DK145497B (da) 1982-11-29
CA1113455A (en) 1981-12-01

Similar Documents

Publication Publication Date Title
SU1303029A3 (ru) Способ получени производных цефалоспорина
JPS6220191B2 (el)
JPS63258479A (ja) アシル誘導体及びその製造方法
FI86430B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva cefalosporinderivat.
JPH04261185A (ja) セファロスポリン化合物
SU1487814A3 (ru) СПОСОБ ПОЛУЧЕНИЯ 7-АМИНО-З-[3(4-КАРБАМОИЛ-1-ПИРИДИНИО)-1-ПРОПЕН1-ИЛ]-3-ЦЕФЕМ-4-КАРБОКСИЛАТА ч.
FI62841B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 7-o-aminometyl- eller metylaminometylfenyl- eller cyklohexa dinyl- eller tienylacetamido)-3-(1-karboximetyl- (eller -et yl eller -propyl-)-tetrazol-5-yltiometyl)-3-cefem-4-karboxy lsror samt deras farmaceutiskt godtagbara salter
FR2465737A1 (fr) 7-(2-(2-amino-4-thiazolyl)-2 - ((1-carboxy-1,1 - dialkyl)alcoxyimino)acetamido)cephem sulfoxydes a action antibacterienne
FI63586C (fi) Foerfarande foer framstaellning av 7-beta-(2-oxiimino-2-arylacetamido)-3-(sulfoalkyltetrazol-5-yltiometyl)-3-cefem-4-karboxylsyror med antibakteriell verkan
FI69849B (fi) Foerfarande foer framstaellning av nya oxazafosforin-4-tio-alkansulfonsyror och deras neutrala salter
FI74971C (fi) Foerfarande foer framstaellning av en terapeutiskt aktiv syn-isomer av en 7-(2-aminotiazolyl-2-hydroxi -iminoacetamido)-3-vinyl-3-cefemfoerening.
FI60869C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara cefalosporiner
FI74020C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 7- -/ -syn-metoxiimino- -(2-aminotiazol-4-yl) acetamido/-3-/(1,2,3-tiadiazol-5-yltio)metyl/-3-cefem-4-karboxylsyraderivat
EP0449515B1 (en) Novel cephalosporin intermediates and process for preparing the intermediates and their end products
US5464829A (en) Cephalosporin derivatives
KR0157073B1 (ko) 세팔로스포린 유도체 및 그의 제조방법
US5332731A (en) Cephalosporin derivatives
US4151352A (en) 7-Amino-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids
DE69706321T2 (de) Cephemderivate
US5143911A (en) Antibiotic c-3 di-hydroxyphenyl substituted cephalosporin compounds, compositions and method of use thereof
NO883219L (no) Framgangsmaate for framstilling av beta-lactam-forbindelse,mellomprodukt for framstilling av denne, og medisinske sammensetninger for behandling av bakteriologiske infeksjonssykdommer inneholdende denne.
KR0154901B1 (ko) 신규 세팔로스포린계 항생제(v)
US4937332A (en) Cephalosporin derivatives
GB1599611A (en) Cephalosporin derivatives
KR890004694B1 (ko) 세팔로스포린 화합물 및 그의 제조 방법

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BRISTOL-MYERS CO